Anita K. Mehta

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Constantia Pantelidou, Olmo Sonzogni, Mateus de Oliveira Taveira et al. · Cancer Discovery · 2019 · 720 citations · Full text

Medicine, Immunology, Oncology +17

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Anita K. Mehta, Emily Cheney, Christina Hartl et al. · Nature Cancer · 2020 · 259 citations · Full text

Medicine, Immunology, Oncology +16

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

Shruti Bhatt, Marissa S. Pioso, Elyse A. Olesinski et al. · Cancer Cell · 2020 · 174 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +16

Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer

Catríona M. Dowling, Kate E.R. Hollinshead, Alessandra Di Grande et al. · Science Advances · 2021 · 67 citations · Full text

Medicine, Biochemistry, Oncology +11

High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype

Nicole Golob‐Schwarzl, Kira Bettermann, Anita K. Mehta et al. · Translational Oncology · 2018 · 39 citations · Full text

Medicine, Molecular Biology, Pathology +17